Search research articles
Contact Us
Filters
Showing results (91-100 of 377) with videos related to
Page
of 38
Sort By:
EJNMMI Research
|
November 12, 2024
Influence of fasting prior to <sup>18</sup>F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake
Sonia Grigorascu, Thomas Langbein, Isabel Rauscher, et al.
Asian Journal of Urology
|
May 17, 2021
Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
Sophie Knipper, Gunhild von Amsberg, Franziska Stolzenbach, et al.
European Journal of Radiology
|
June 9, 2009
Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging
Konstantin Holzapfel, Melanie Bruegel, Matthias Eiber, et al.
Medical Physics
|
November 27, 2020
Important pharmacokinetic parameters for individualization of <sup>177</sup> Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic model
Deni Hardiansyah, Peter Kletting, Nusrat J Begum, et al.
EJNMMI Research
|
April 14, 2018
Synthesis and preclinical evaluation of novel <sup>18</sup>F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with <sup>18</sup>F-DCFPyl and <sup>18</sup>F-PSMA-1007
Stephanie Robu, Alexander Schmidt, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 21, 2015
68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer
Thomas Pyka, Gregor Weirich, Ingo Einspieler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2019
Matched-Pair Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and <sup>18</sup>F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy
Isabel Rauscher, Markus Krönke, Michael König, et al.
Clinical Nuclear Medicine
|
August 15, 2012
A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer
Toshiki Takei, Michael Souvatzoglou, Ambros J Beer, et al.
European Urology Open Science
|
December 1, 2025
Radical Prostatectomy Combined with Prostate Specific Membrane Antigen-radioguided Lymph Node Dissection is Associated with Longer Treatment-free Survival for Patients with Primary Lymph Node-positive Prostate Cancer
Philipp Korn, Flemming Lischewski, Helena Staehler, et al.
EJNMMI Physics
|
June 26, 2024
DosePatch: physics-inspired cropping layout for patch-based Monte Carlo simulations to provide fast and accurate internal dosimetry
Francesca De Benetti, Julia Brosch-Lenz, Jorge Mario Guerra González, et al.
Page
of 38
Search research articles
Search
Showing results (91-100 of 377) with videos related to
Sort By:
Page
of 38
EJNMMI Research
|
November 12, 2024
Influence of fasting prior to <sup>18</sup>F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake
Sonia Grigorascu, Thomas Langbein, Isabel Rauscher, et al.
Asian Journal of Urology
|
May 17, 2021
Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
Sophie Knipper, Gunhild von Amsberg, Franziska Stolzenbach, et al.
European Journal of Radiology
|
June 9, 2009
Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging
Konstantin Holzapfel, Melanie Bruegel, Matthias Eiber, et al.
Medical Physics
|
November 27, 2020
Important pharmacokinetic parameters for individualization of <sup>177</sup> Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic model
Deni Hardiansyah, Peter Kletting, Nusrat J Begum, et al.
EJNMMI Research
|
April 14, 2018
Synthesis and preclinical evaluation of novel <sup>18</sup>F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with <sup>18</sup>F-DCFPyl and <sup>18</sup>F-PSMA-1007
Stephanie Robu, Alexander Schmidt, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 21, 2015
68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer
Thomas Pyka, Gregor Weirich, Ingo Einspieler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2019
Matched-Pair Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and <sup>18</sup>F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy
Isabel Rauscher, Markus Krönke, Michael König, et al.
Clinical Nuclear Medicine
|
August 15, 2012
A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer
Toshiki Takei, Michael Souvatzoglou, Ambros J Beer, et al.
European Urology Open Science
|
December 1, 2025
Radical Prostatectomy Combined with Prostate Specific Membrane Antigen-radioguided Lymph Node Dissection is Associated with Longer Treatment-free Survival for Patients with Primary Lymph Node-positive Prostate Cancer
Philipp Korn, Flemming Lischewski, Helena Staehler, et al.
EJNMMI Physics
|
June 26, 2024
DosePatch: physics-inspired cropping layout for patch-based Monte Carlo simulations to provide fast and accurate internal dosimetry
Francesca De Benetti, Julia Brosch-Lenz, Jorge Mario Guerra González, et al.
Page
of 38